Disc Medicine, Inc.
IRONNASDAQHealthcare● Active
$65.62
$-1.38(-2.06%)
Market Cap$2.5B
P/E Ratio—
52W High$99.5
52W Low$40
Disc Medicine, Inc. (IRON) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IRON · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$1.65
Est. -$1.55 · -6.5%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS
IRON reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$1.71 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 5, 2026 | -$1.55 | -$1.65 | -6.5% | — | $0.00B | — |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$1.69 | -$1.62 | +4.1% | — | $0.00B | — |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$1.48 | -$1.77 | -19.6% | — | — | — |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$1.17 | -$1.58 | -35.0% | — | — | — |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.99 | -$1.02 | -3.0% | — | — | — |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$1.06 | -$0.98 | +7.5% | — | — | — |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.98 | -$0.89 | +9.2% | — | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$1.71
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
-$1.65
EPS Est.
-$1.55
EPS Surpr.
-6.5%
Revenue
—
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$1.62
EPS Est.
-$1.69
EPS Surpr.
+4.1%
Revenue
—
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$1.77
EPS Est.
-$1.48
EPS Surpr.
-19.6%
Revenue
—
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$1.58
EPS Est.
-$1.17
EPS Surpr.
-35.0%
Revenue
—
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$1.02
EPS Est.
-$0.99
EPS Surpr.
-3.0%
Revenue
—
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
-$0.98
EPS Est.
-$1.06
EPS Surpr.
+7.5%
Revenue
—
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.89
EPS Est.
-$0.98
EPS Surpr.
+9.2%
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-1.60 | $-1.60 | $-1.60 | 6 |
| Q3 FY2027 | $-1.85 | $-1.85 | $-1.85 | 3 |
| Q2 FY2027 | $-1.92 | $-1.92 | $-1.92 | 5 |
| Q1 FY2027 | $-1.85 | $-1.85 | $-1.85 | 3 |
| Q4 FY2026 | $-1.86 | $-1.86 | $-1.86 | 6 |
| Q3 FY2026 | $-1.99 | $-1.78 | $-1.48 | 8 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 10 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -6.5% | $67.64 | $67.59 | -0.07% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +4.1% | $66.89 | $67.91 | +1.52% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -19.6% | $88.31 | $87.00 | -1.48% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -35.0% | $59.00 | $57.07 | -3.27% |
| ▼ Q2 FY2025 | May 7, 2025 | -3.0% | $42.58 | $43.55 | +2.28% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +7.5% | $54.46 | $54.50 | +0.07% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +9.2% | $66.57 | $63.26 | -4.97% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +7.2% | $41.27 | $42.85 | +3.83% |
Q2 FY2026-0.07%
Report Date
May 5, 2026
EPS Beat/Miss
-6.5%
Price Before
$67.64
Price After
$67.59
Q1 FY2026+1.52%
Report Date
Feb 26, 2026
EPS Beat/Miss
+4.1%
Price Before
$66.89
Price After
$67.91
Q4 FY2025-1.48%
Report Date
Nov 6, 2025
EPS Beat/Miss
-19.6%
Price Before
$88.31
Price After
$87.00
Q3 FY2025-3.27%
Report Date
Aug 7, 2025
EPS Beat/Miss
-35.0%
Price Before
$59.00
Price After
$57.07
Q2 FY2025+2.28%
Report Date
May 7, 2025
EPS Beat/Miss
-3.0%
Price Before
$42.58
Price After
$43.55
Q1 FY2025+0.07%
Report Date
Feb 27, 2025
EPS Beat/Miss
+7.5%
Price Before
$54.46
Price After
$54.50
Q4 FY2024-4.97%
Report Date
Nov 12, 2024
EPS Beat/Miss
+9.2%
Price Before
$66.57
Price After
$63.26
Q3 FY2024+3.83%
Report Date
Aug 8, 2024
EPS Beat/Miss
+7.2%
Price Before
$41.27
Price After
$42.85
Avg Beat Reaction+0.11%
Avg Miss Reaction-0.64%
Beat Rate4 / 8 quarters
Largest Move-4.97% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IRON ends December
Disc Medicine, Inc. (IRON) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-1.65 — missing the analyst consensus of $-1.55 by -6.5%. The next IRON earnings date is expected around September 1, 2026.
Each quarter, investors track IRON earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IRON revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IRON's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IRON earnings · 5 questionsDisc Medicine, Inc.'s next earnings report is expected around September 1, 2026. IRON typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IRON historically reports after market close (AMC).
IRON earnings datewhen is IRON earningsIRON next earnings datewhen does IRON report earningsIRON earnings calendar
▸ Source: FMP · Disc Medicine, Inc. SEC filings · US GAAP · Disc Medicine, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026